Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and ...

Roche has inked a new deal with Dyno Therapeutics to develop next-generation AAV capsids for gene therapies targeting ...

Mar­i­nus Phar­ma­ceu­ti­cals is re­duc­ing its work­force again and tak­ing oth­er mea­sures to re­duce costs af­ter its ...

Zai Lab released Phase 1a data Thursday morning as it attempts to compete with a recently approved Amgen drug. The program, ...

Plus, news about Interius BioTherapeutics, Hope Medicine, PMV Pharmaceuticals, Epitopea, Alyssum Therapeutics and a new dementia trial accelerator in the UK: Bayer exercises option to develop heart ...

MGM Resorts plans to stop covering GLP-1 weight loss shots for its employees next year, after it faced constraints in what it ...

Novo Nordisk is continuing its crusade against compounded versions of its blockbuster weight loss drugs by petitioning the ...

GSK is presenting its case for broader use of its RSV vaccine with new data from a pair of studies in younger adults with ...

Precision Biosciences has received clearance from regulators in the Eastern European country of Moldova to begin a human ...

More people are now advised to get a pneumococcal vaccine if they haven’t already, as CDC advisors recommended the shots for ...

Americans as young as 18 with a chronic condition can now receive an RSV vaccine after Pfizer snagged expanded FDA approval ...

Thermo Fisher told investors it is ready to shut the door on 2024, anticipating biotech funding to improve and lingering ...